Hydrocodone Bitartrate and Acetaminophen

This page contains recent news articles, when available, and an overview of Hydrocodone Bitartrate and Acetaminophen but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Questcor Resubmits Supplemental New Drug Application to FDA for HP ...  -  Dec 2, 2008
The Company is also developing QSC-001, a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of MarketWatch

BUYINS.NET: Market Maker Surveillance Report. Top 6 Highest Net ...  -  Dec 5, 2008
...including QSC-001, an orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of moderate to moderately Trading Markets (press release),

Questcor to Present At the Rodman & Renshaw 10th Annual Healthcare ...  -  Nov 3, 2008
The Company is also developing QSC-001, a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of MarketWatch

Questcor Pharmaceuticals Evaluating Acthar(r) Gel as a Potential ...  -  Oct 28, 2008
The Company is also developing QSC-001, a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of MarketWatch

Questcor Reports Strong Results for the Third Quarter 2008  -  Oct 30, 2008
The Company is also developing QSC-001, a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of MarketWatch

Questcor Announces Third Quarter 2008 Earnings Release Date and ...  -  21 Oct 2008
The Company is also developing QSC-001, a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of MarketWatch

Questcor Pharmaceuticals to Present at 2008 Southern California ...  -  Aug 25, 2008
The Company is also developing QSC-001, a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of MarketWatch

Questcor Repurchases 1.8 Million Common Shares From Inverlochy ...  -  Sep 4, 2008
The Company is also developing QSC-001, a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of MarketWatch

Questcor Announces CFO Transition Plan  -  Aug 5, 2008
The Company is also developing QSC-001, a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of MarketWatch

Questcor Reports Second Quarter Results  -  Jul 24, 2008
The Company is also developing QSC-001, a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of MarketWatch

Questcor to Present At the 2008 BMO Capital Markets Focus On ...  -  Jul 31, 2008
The Company is also developing QSC-001, a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of MarketWatch

Questcor Pharmaceuticals Announces Preliminary Second Quarter 2008 ...  -  03 Jul 2008
The Company is also developing QSC-001, a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of PharmaLive.com (press release),

Questcor Included in Russell 3000 Index  -  Jun 30, 2008
...a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of moderate to moderately severe pain. FOXBusiness

New Abbott Study of Investigational Vicodin CR(TM) Meets Primary ...  -  May 8, 2008
TAMPA, May 8 -- New Phase III study data showed that Abbott's investigational hydrocodone bitartrate and acetaminophen (HC/APAP) extended release medicine Earthtimes (press release),

Abbott’s investigational drug for lower back pain meets primary ...  -  May 8, 2008
Clinical trials of the investigational hydrocodone bitartrate and acetaminophen or HC/APAP, extended release medicine revealed that two 12-hour dosing of RTT News,

Questcor to Commence Trading on NASDAQ Today  -  May 16, 2008
...a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of moderate to moderately severe pain. Earthtimes (press release),

Questcor to Provide Q1 Results  -  Apr 22, 2008
...a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of moderate to moderately severe pain. Earthtimes,

Questcor to Present at Cowen and Company 28th Annual Health Care ...  -  11 Mar 2008
...a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of moderate to moderately severe pain. Business Wire (press release),

Police Blotter  -  Feb 29, 2008
The employee gave the robber bottles of hydrocodone bitartrate and acetaminophen. The robber then left the pharmacy, and witnesses outside the store told Spartanburg Herald Journal (subscription),

Calvert County Sheriff's Reports  -  Mar 3, 2008
...arrested Dwayne A. Presgraves, Jr., 29 of Lusby and charged him with possession of a schedule 2 drug (Hydrocodone Bitartrate and Acetaminophen). Southern Maryland Online,

Westville man's bond forfeited; warrant issued for his arrest  -  Jan 30, 2008
He allegedly broke a back door handle and lock with the intent to steal prescription medication, including Hydrocodone, Bitartrate and Acetaminophen. Tahlequah Daily Press,

Questcor to Provide Acthar Update  -  Jan 10, 2008
...a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of moderate to moderately severe pain. PR-USA.net (press release),

Questcor Appoints Stephen Farrell to Board of Directors  -  Nov 15, 2007
...a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of moderate to moderately severe pain. Business Wire (press release),

Questcor Announces Financial Results for 2007 First Quarter  -  May 11, 2007
PharmaLive.com (press release),Reformulation work began for QSC-001, our unique orally disintegrating tablet (ODT) formulation of hydrocodone bitartrate and acetaminophen (HB/APAP) for

OWI arrest leads to narcotics investigation  -  Jan 16, 2007
Greater Milwaukee Today,The label on the bottle identified the pills as "hydrocodone bitartrate and acetaminophen." The bottle contained 387 pills, according to the complaint.

Questcor Announces Initiation of Clinical Program for QSC-001  -  Nov 28, 2006
PipelineReview.com (press release),...disintegrating tablet (ODT) formulation of hydrocodone bitartrate and acetaminophen (HB/APAP) for the treatment of moderate to moderately severe pain.

Market Report -- In Play (WIRES)  -  Nov 27, 2006
MSN Money...a unique orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of moderate to moderately severe pain.

Accentia Biopharmaceuticals Reports Financial Results for Second ...  May 15, 2006
...by FDA: Accentia's manufacturing partner received approval from the FDA for two new dosages of Xodol (hydrocodone bitartrate and acetaminophen tablets, USP ... - Genetic Engineering News

Accentia Biopharmaceuticals Receives FDA Approval for Three Unique ...  May 8, 2006
..."Our sales force has been very effective in establishing our presence in the pain market with our Xodol (hydrocodone bitartrate and acetaminophen tablets, USP ... - Genetic Engineering News

Accentia Biopharmaceuticals, Inc. Diversifies Pain Product ...  Mar 30, 2006
...partner received approval from the US Food and Drug Administration (FDA) for a new dosage of Xodol(R) (hydrocodone bitartrate and acetaminophen tablets, USP ... - Genetic Engineering News

Accentia Increases Pain Management Options  Mar 31, 2006
...subsidiary, Teamm Pharmaceuticals, Accentia will now be able to produce a new dosage of Xodol (hydrocodone bitartrate and acetaminophen tablets, USP), giving ... - International News Service

Accentia Biopharmaceuticals Expands Unique Combination Pain ... Feb 13, 2006
TEAMM to expand our pain product portfolio, thus capitalizing on the franchise we started with Xodol (hydrocodone bitartrate and acetaminophen tablets, USP ... - Genetic Engineering News,

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com/health lead to other sites. health.mongabay.com/health does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com/health responsible for dead or misdirected links.